Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Buck, Martina ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; CD34 ANTIGEN; CD81 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; CR1 PROTEIN, HUMAN; GLIAL FIBRILLARY ACIDIC PROTEIN; HGF PROTEIN, HUMAN; INTERFERON; LEUKOCYTE ANTIGEN; SCATTER FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOST CELL; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MICROBIAL KINETICS; NONHUMAN; VIRION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL LINE; CYTOLOGY; GENETICS; KINETICS; LIVER; LIVER CELL; METABOLISM; PATHOGENICITY; VIROLOGY;

HEPATITIS C VIRUS;

ANTIGENS, CD; ANTIGENS, CD34; CELL CYCLE; CELL LINE; CELLS, CULTURED; GENOTYPE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEPACIVIRUS; HEPATITIS C; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; INTERFERONS; KINETICS; LIVER; RECEPTORS, COMPLEMENT 3B;

EID: 50549101223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002660     Document Type: Article

References (60)

1. Hepatitis C: global prevalence: Wkly Epidemiol Rec 72: 341-344.
2. Alter HJ, Seeff LB (2000) Recovery, persistence and sequelae in hepatitis C virus infection: a perspective on the long-term outcome. Semin Liv Dis 20: 17-25.
3. Shimotohno K (2000) Hepatitis C virus and its pathogenesis. Semin Cancer Biol 10: 233-240.
4. Report 04-5491 (2004) Viral Hepatitis; Action Plan for Liver Disease Research. U.S. Department of Health and Human Services, NIH. pp 61-69.
5. Manns MP, McHutchinson JG, Gordon SC, Rustgi VK, Shiffman M, et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958-965.
6. Williams BRG, Sen GC (2003) Immunology: A viral on/off switch for interferon. Science 300(5622): 1100-1101.
7. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete Replication of Hepatitis C Virus in Cell Culture. Science 306: 623-6.
8. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102(26): 9294-9299.
9. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 11: 791-6.
10. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A 103(7): 2310-2315.
11. Murakami K, Ishii K, Ishihara Y, Yoshizaki S, Tanaka K, et al. (2006) Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. Virology 351(2): 381-392.
12. Lindenbach BD, Meuleman P, Ploss A, Vanwolleghem T, Syder AJ, et al. (2006) Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 103(10): 3500-3501.
13. Aly HH, Watashi K, Hijikata M, Kaneko H, Takada Y, et al. (2007) Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J Hepatol 46(1): 26-36.
14. Durantel D, Zoulim F (2007) Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions? J Hepatol 46(1): 1-5.
15. Kroemer G, Jaattela M (2005) Lysosomes and autophagy in cell death control. Nat Rev Cancer 5(11): 886-897.
16. Jones SM, Howell KE, Henley JR, Cao H, McNiven MA (1998) Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science 279(5350): 573-577.
17. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T (2005) Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 168(3): 477-488.
18. Buck M, Zhang L, Hunter T, Chojkier M (2001) Nuclear export of phosphorylated C/EBPβ mediates the inhibition of albumin expression by TNFα. EMBO J 20: 6712-6723.
19. Buck M, Poli V, Hunter T, Chojkier M (2001) C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell 8: 807-816.
20. Buck M, Chojkier M (1996) Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15: 1753-1765.
21. Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, et al. (1993) p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14(5): 987-992.
22. Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS, et al. (2006) Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology 43(5): 1042-1052.
23. Nagao K, Ohyashiki JH, Ohyashiki K, Tabata K, Takai K, et al. (2005) Expression of hTERT mRNA in a mortal liver cell line during S phase without detectable telomerase activity. Int J Mol Med 15(4): 683-688.
24. Yokoo H, Kondo T, Fujii K, Yamada T, Taco S, et al. (2004) Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology 40(3): 609-617.
25. Fournier C, Sureau C, Coste J, Ducos J, Pageaux G, et al. (1998) In vitro infection of adult normal hepatocytes in primary culture by hepatitis C virus. J Gen Virol 79: 2367-2374.
26. Molina S, Castet V, Founier-Wirth C, Richard-Garcia L, Avner B, et al. (2007) The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 46: 411-419.
27. Molina S, Castet V, Richard-Garcia L, Wychowski C, Meurs K, et al. (2008) Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 82(1): 569-574.
28. Buck M, Poli V, van der Geer P, Chojkier M, Hunter T (1999) Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBPβ is required for hepatocyte proliferation induced by TGFα. Mol Cell 4: 1087-1092.
29. Michalopoulos GK, Bowen WC, Mule K, Stolz DB (2001) Histological organization in hepatocyte organoid cultures. Am J Pathol 159(5): 1877-1887.
30. -/- Mice. Nature Immunology 4(3): 255-260.
31. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, et al. (2003) Angiogenesis-independent endothelial protection of liver, role of VEGFR-1. Science 299: 890-893.
32. Helmy KY, Katschke KJ Jr, Gorgiani NN, Klajvin NM, Elliott JM, et al. (2006) CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124(5): 29-32.
33. Lepreux S, Bioulac-Sage P, Gabbiani G, Sapin V, Housset C, et al. (2004) Cellular retinal-binding protein-1 expression in normal and fibrotic/ cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations. J Hepatol 40(5): 774-780.
34. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, et al. (2004) Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A 101(13): 4477-4482.
35. Michalopoulos GK, Bowen WC, Zajac VF, Beer-Stolz D, Watkins S, et al. (1999) Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology 29: 90-100.
36. Cho MK, Kim SG (2003) Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway. Hepatology 37(3): 686-695.
37. Buck M, Chojkier M (2002) A ribosomal S-6 kinase-mediated signal to C/ EBP-beta is critical for the development of liver fibrosis. PLOS One 2007; 2(12): e1372.
38. De Vos R, Verslype C, Depla E, Fevery J, Van Damme B, et al. (2002) Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies. J Hepatol 37(3): 370-379.
39. Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H (1996) Hepatitis C virus: Detection of intracellular virus particles by electron microscopy. Hepatology 23: 205-209.
40. Neumann A, Lam N, Dahari H, Gretch D, Wiley T, et al. (1998) Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282(5386): 103-107.
41. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, et al. (1998) Binding of hepatitis C virus to CD81. Science 282(5390): 938-941.
42. Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV (2007) Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol 81(1): 374-383.
43. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, et al. (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80(14): 6964-6972.
44. Meertens L, Bertaux C, Dragic T (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80(23): 11571-11578.
45. Aizaki H, Lee KJ, Sung VM, Ishiko H, Lai MM (2004) Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324(2): 450-461.
46. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, et al. (2006) Time- and temperature dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80(4): 1734-1741.
47. Le Pogam S, Jiang WR, Leveque V, Raivaquru S, Ma H, et al. (2006) In vitro selected Con1 subgenomic replicons resistant to 2′-C-methyl-cytidine or to R1479 show lack of cross resistance. Virology 351(2): 349-359.
48. Chung R, Gale M Jr, Polyak S, Lemon SM, Liang TJ, et al. (2007) Mechanisms of action of interferon and ribavirin in chronic hepatitis C: summary of a workshop. AASLD; 306.
49. Miyamoto H, Okamoto H, Sato K, Tanaka T, Mishiro S (1992) Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol 73: 715-718.
50. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, et al. (1993) Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 67(4): 1953-1958.
51. Yi M, Ma Y, Yates J, Lemon SM (2007) Compensatory mutations in E1, p7, NS2, and NS3 entrance yields of cell culture-infectious Intergenotypic chimeric hepatitis C virus. J Virol 81(2): 629-638.
52. Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G, et al. (2003) An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 308; 426(6963): 186-189.
53. Patel K, Zekry A, McHutchinson JG (2005) Steatosis and chronic hepatitis C virus infection: mechanisms and significance. Clin Liv Dis 9(3): 399-410.
54. Mueller S, Afdhal NH, Schuppan H (2006) Iron, HCV, and liver cancer: hard metal setting the pace? Gastroenterology 130(7): 2229-2234.
55. Lau DT, Fish PM, Sinha M, Owen DM, Lemon SM, et al. (2008) Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients. Hepatology 47(3): 799-809.
56. Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, et al. (2002) Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J Clin Invest 109(2): 221-232.
57. Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13: 29-83.
58. Buck M, Turler H, Chojkier M (1994) LAP (NF-IL6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO J 13: 851-860.
59. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, et al. (1993) Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364: 544-547.
60. Rudel T, Bokoch G (1997) Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276: 1571-1574.